Theratechnologies (TSE:TH) Share Price Crosses Above Fifty Day Moving Average - Should You Sell?

Key Points

• Theratechnologies Inc. stock has recently surpassed its 50-day moving average of C$4.14, trading as high as C$4.51; the last trading price was C$4.50.
• Jones Trading downgraded the stock from a "strong-buy" to a "hold" rating, with the average rating currently being "Buy" based on analyst evaluations.
• The company has a market capitalization of C$143.57 million and operates primarily in the specialty pharmaceutical sector, focusing on HIV treatment.

Theratechnologies Inc. (TSE:TH - Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$4.14 and traded as high as C$4.51. Theratechnologies shares last traded at C$4.50, with a volume of 11,975 shares.

Wall Street Analysts Forecast Growth

Separately, Jones Trading downgraded Theratechnologies from a "strong-buy" rating to a "hold" rating in a research note on Thursday, July 3rd. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy".

Theratechnologies Price Performance

The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of -293.92. The company has a market cap of C$204.61 million, a P/E ratio of -23.42, a PEG ratio of -8.50 and a beta of 0.30. The business's fifty day moving average is C$4.22 and its 200 day moving average is C$3.45.

Theratechnologies Company Profile

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.